BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8745041)

  • 1. Hydrolysis of cyclosporin A: identification of 1,11 seco-cyclosporin A and 4,5 seco-isocyclosporin A by FAB-MS/MS.
    Magni F; Arnoldi L; Del Puppo M; Galli Kienle M
    Peptides; 1995; 16(8):1335-41. PubMed ID: 8745041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of cyclosporin A from isocyclosporin A by liquid chromatography/electrospray ionization mass spectrometry with post-column addition of divalent metal salt.
    Cirigliano AM; Cabrera GM
    Rapid Commun Mass Spectrom; 2014 Mar; 28(5):465-70. PubMed ID: 24497284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-chain peptides obtained by acidic hydrolytic cleavage of cyclosporin A.
    Magni F; Arcelloni C; Paroni R; Fermo I; Bonini PA; Del Puppo M; Manzocchi A; Galli Kienle M
    Biol Mass Spectrom; 1994 Aug; 23(8):514-8. PubMed ID: 7918693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of acid-catalyzed degradation of cyclosporin A and its analogs in aqueous solution.
    Oliyai R; Safadi M; Meier PG; Hu MK; Rich DH; Stella VJ
    Int J Pept Protein Res; 1994 Mar; 43(3):239-47. PubMed ID: 8005746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of cyclosporine metabolites.
    Yatscoff RW; Rosano TG; Bowers LD
    Clin Biochem; 1991 Feb; 24(1):23-35. PubMed ID: 2060129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous N --> O acyl shift in the [M + H](+) ions of [MeBmt1]-cyclosporins in an ion trap.
    Jegorov A; Havlícek V
    J Mass Spectrom; 2001 Jun; 36(6):633-40. PubMed ID: 11433536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of cyclosporins by high-performance liquid chromatography and mass spectrometric study of cyclosporin metabolites.
    Tuominen J; Suortti T; Ishikawa K; Lundell J; Koga Y
    Rapid Commun Mass Spectrom; 1998; 12(16):1085-91. PubMed ID: 9737014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient production of the cyclosporin metabolite AM1 by rabbit hepatic enzymes.
    Paroni R; Fermo I; Iavarone L; Del Puppo M; De Angelis L; Galli Kienle M
    Pharmacol Res; 1993; 28(1):73-84. PubMed ID: 8234147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics and mechanism of isomerization of cyclosporin A.
    Oliyai R; Stella VJ
    Pharm Res; 1992 May; 9(5):617-22. PubMed ID: 1608891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BF3-catalysed methanolysis combined with fast atom bombardment tandem mass spectrometry as a new tool for the preparation and analysis of linear secocyclosporins.
    Havlícek V; Jegorov A; Sedmera P; Ryska M
    Rapid Commun Mass Spectrom; 1995; Spec No():S158-64. PubMed ID: 8829477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The isolation, structural characterization, and immunosuppressive activity of cyclosporin G (NVa2-cyclosporine) metabolites.
    Copeland KR; Yatscoff RW
    Ther Drug Monit; 1991 Jul; 13(4):281-8. PubMed ID: 1780958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological conversion of a water-soluble prodrug of cyclosporine A.
    Lallemand F; Varesio E; Felt-Baeyens O; Bossy L; Hopfgartner G; Gurny R
    Eur J Pharm Biopharm; 2007 Sep; 67(2):555-61. PubMed ID: 17475453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and structural identification of 9hydroxy-9desmethyl-cyclosporine.
    Bowers LD; Norman DD; Yan XX; Scheeler D; Carlson KL
    Clin Chem; 1990 Nov; 36(11):1875-9. PubMed ID: 2242562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free biosynthesis of cyclosporin A and analogues.
    Kleinkauf H; Dittmann J; Lawen A
    Biomed Biochim Acta; 1991; 50(10-11):S219-24. PubMed ID: 1820050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A conformation of cyclosporin A in aqueous environment revealed by the X-ray structure of a cyclosporin-Fab complex.
    Altschuh D; Vix O; Rees B; Thierry JC
    Science; 1992 Apr; 256(5053):92-4. PubMed ID: 1566062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel antibiotics, amythiamicins. II. Structure elucidation of amythiamicin D.
    Shimanaka K; Takahashi Y; Iinuma H; Naganawa H; Takeuchi T
    J Antibiot (Tokyo); 1994 Oct; 47(10):1145-52. PubMed ID: 7961165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural characterization of two novel oxidative derivatives of cyclosporine generated by a chemical method.
    Liu WT; Marat K; Ren Y; Eng RT; Wong PY
    Clin Biochem; 1998 Apr; 31(3):173-80. PubMed ID: 9629491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubility and mass and nuclear magnetic resonance spectroscopic studies on interaction of cyclosporin A with dimethyl-alpha- and -beta-cyclodextrins in aqueous solution.
    Miyake K; Hirayama F; Uekama K
    J Pharm Sci; 1999 Jan; 88(1):39-45. PubMed ID: 9874700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of water molecules in the structure-based design of (5-hydroxynorvaline)-2-cyclosporin: synthesis, biological activity, and crystallographic analysis with cyclophilin A.
    Mikol V; Papageorgiou C; Borer X
    J Med Chem; 1995 Aug; 38(17):3361-7. PubMed ID: 7650689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of cyclosporine and some derivatives with model membranes: binding and ion permeability changes.
    Fahr A; Nimmerfall F; Wenger R
    Transplant Proc; 1994 Oct; 26(5):2837-41. PubMed ID: 7940894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.